14-day Premium Trial Subscription Sign Up For FreeGet Free

Durect Corporation Stock Forecast NASDAQ:DRRX

Price Target and Analyst Ratings

Most Recent Rating

HC Wainwright is very positive about DRRX and gave it a "Buy" rating on May 11, 2021. The price target was set to $6.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-11 Buy Reiterated by HC Wainwright $1.72 $6.00
2021-05-05 Buy Reiterated by HC Wainwright $1.77 $6.00
2021-02-03 Buy Target Raised by Chardan Capital $2.87 $7.00 → $8.00
2020-11-26 Buy Reiterated by Chardan Capital $1.86 $7.00
2020-10-30 Buy Initiated by Chardan Capital $1.81 $7.00
2020-10-12 Buy Initiated by Roth Capital $1.96 $7.00
2020-10-12 Buy Initiated by Roth Capital $1.96
2020-07-30 Outperform Initiated by Oppenheimer $1.94 $7.00
2020-06-29 Buy Reiterated by B. Riley $2.50 $5.00
2020-05-27 Buy Target Raised by HC Wainwright $2.60 $5.50 → $6.00
2020-05-12 Buy Reiterated by HC Wainwright $2.73 $5.50

DRRX Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -14.63% during the next 3 months and, with a 90% probability hold a price between $0.99 and $1.23 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-30 $1.16 $1.30 $1.44
2021-10-01 $1.16 $1.30 $1.43
2021-10-04 $1.15 $1.29 $1.43
2021-10-05 $1.15 $1.29 $1.43
2021-10-06 $1.14 $1.28 $1.42
2021-10-07 $1.14 $1.28 $1.42
2021-10-08 $1.14 $1.28 $1.42
2021-10-11 $1.13 $1.27 $1.41
2021-10-12 $1.13 $1.27 $1.41
2021-10-13 $1.12 $1.26 $1.40
2021-10-14 $1.12 $1.26 $1.40
2021-10-15 $1.12 $1.26 $1.40
2021-10-18 $1.11 $1.25 $1.39
2021-10-19 $1.11 $1.25 $1.39
2021-10-20 $1.10 $1.24 $1.38
2021-10-21 $1.10 $1.24 $1.38
2021-10-22 $1.10 $1.24 $1.38
2021-10-25 $1.09 $1.23 $1.37
2021-10-26 $1.09 $1.23 $1.37
2021-10-27 $1.08 $1.22 $1.36
2021-10-28 $1.08 $1.22 $1.36
2021-10-29 $1.08 $1.22 $1.36
2021-11-01 $1.07 $1.21 $1.35
2021-11-02 $1.07 $1.21 $1.35
2021-11-03 $1.06 $1.20 $1.34
2021-11-04 $1.06 $1.20 $1.34
2021-11-05 $1.06 $1.20 $1.34
2021-11-08 $1.05 $1.19 $1.33
2021-11-09 $1.05 $1.19 $1.33
2021-11-10 $1.05 $1.19 $1.33

About Durect Corporation

Durect DURECT Corporation, a biopharmaceutical company, researches and develops therapies based on its epigenomic regulator program and proprietary drug delivery platforms. The company offers ALZET product line that includes osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for use as raw materials for pharmaceutical and medical devices under the LACTEL brand. ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT